Skip to main content

Advertisement

Figure 6 | BMC Research Notes

Figure 6

From: Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses

Figure 6

Relationship of serum Trx1 levels in patients with breast cancer with age and status of menopause. Clinical information for patients with breast cancer was provided by the supplier. The individual values are the average values of three measurements. Panel A denotes no relationship between serum level of Trx1 and age of breast cancer patient. Panel B shows no relationship between serum level of Trx1 and menopause status of patient with breast cancer.

Back to article page